Dihydroartemisinin suppresses growth of squamous cell carcinoma A431 cells by targeting the Wnt/β-catenin pathway

Anti-Cancer Drugs

Volumn 27, Issue 2, 2016, Pages 99-105

  Hui, Hai Ying ^a   Wu, Na ^a   Wu, Min ^a   Liu, Yang ^a   Xiao, Sheng Xiang ^a   Zhang, Mei Fang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

A431 cells; Dihydroartemisinin; Skin cancer; Wnt catenin

Indexed keywords

BETA CATENIN; CASPASE 3; DIHYDROARTEMISININ; MESSENGER RNA; SURVIVIN; WNT PROTEIN; ANTINEOPLASTIC AGENT; ARTEMISININ DERIVATIVE; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MTT ASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN CANCER; SQUAMOUS CELL CARCINOMA CELL; WESTERN BLOTTING; CARCINOMA, SQUAMOUS CELL; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PATHOLOGY; SKIN NEOPLASMS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARTEMISININS; BETA CATENIN; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; WNT PROTEINS;

EID: 84952700824     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0000000000000307     Document Type: Article

References (43)

1. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012;166:1069-1080.
2. Belkin DA, Mitsui H, Wang CQ, Gonzalez J, Zhang S, Shah KR, et al. CD200 upregulation in vascular endothelium surrounding cutaneous squamous cell carcinoma. JAMA Dermatol 2013;149:178-186.
3. Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ, et al. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 2002;20:1063-1068.
4. Huang K, Huang Y, Diao Y. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway. International Immunopharmacol 2012;12:334-341.
5. Chen P, Wang Z-q, Hua L, Zhou P. Surviving gene expression and progression of cervical intraepithelial neoplasia: a systematic review with meta-analysis. Computational and Information Sciences (ICCIS), 2013 Fifth International Conference; 21-23 June 2013; Shiyang: IEEE. pp. 245-248.
6. Dallaglio K, Marconi A, Pincelli C. Survivin: a dual player in healthy and diseased skin. J Invest Dermatol 2012;132:18-27.
7. Ba Q, Zhou N, Duan J, Chen T, Hao M, Yang X, et al. Dihydroartemisinin exerts its anticancer activity through depleting cellular iron via transferrin receptor-1. PLoS One 2012;7:e42703.
8. Charman SA, Arbe-Barnes S, Bathurst IC, Brun R, Campbell M, Charman WN, et al. Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. P Natl Acad Sci 2011;108:4400-4405.
9. Veiga MI, Ferreira PE, Jörnhagen L, Malmberg M, Kone A, Schmidt BA, et al. Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance. PloS One 2011;6:e20212.
10. Lai H, Singh NP. Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett 1995;91:41-46.
11. Efferth T, Olbrich A, Bauer R. mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether. Biochem Pharmacol 2002;64:617-623.
12. Liu Y, Wang W, Xu J, Li L, Dong Q, Shi Q, et al. Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/β-catenin signaling. Oncol Rep 2013;30:1723-1730.
13. Mao H, Gu H, Qu X, Sun J, Song B, Gao W, et al. Involvement of the mitochondrial pathway and Bim/Bcl-2 balance in dihydroartemisinin-induced apoptosis in human breast cancer in vitro. Int J Mol Med 2013;31:213-218.
14. Sun S-N, Jia W-D, Chen H, Ma J-L, Ge Y-S, Yu J-H, et al. Docosahexaenoic acid (DHA) induces apoptosis in human hepatocellular carcinoma cells. Int J Clin Exp Pathol 2013;6:281.
15. Gu Z, Suburu J, Chen H, Chen YQ. Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention. Biomed Res Int 2013;2013:824563.
16. Li R, Liu J, Wu H, Liu L, Wang L, Zhang S. TIKI2 suppresses growth of osteosarcoma by targetingWnt/β-catenin pathway. Mol Cell Biochem 2014;392:109-116.
17. Muzio LL, Staibano S, Pannone G, Mignogna MD, Mariggiò A, Salvatore G, et al. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol 2001;70:249-254.
18. Altieri DC. Targeting survivin in cancer. Cancer Lett 2013;332:225-228.
19. Alajez NM, Lenarduzzi M, Ito E, Hui AB, Shi W, Bruce J, et al. MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res 2011;71:2381-2391.
20. Jha K, Shukla M, Pandey M. Survivin expression and targeting in breast cancer. Surg Oncol 2012;21:125-131.
21. Katalinic A, Waldmann A, Weinstock MA, Geller AC, Eisemann N, Greinert R, et al. Does skin cancer screening save lives? Cancer 2012;118:5395-5402.
22. Lu J-J, Bao J-L, Chen X-P, Huang M, Wang Y-T. Alkaloids isolated from natural herbs as the anticancer agents. Evid-Based Compl 2012;2012:485042.
23. Mondal S, Bandyopadhyay S, Ghosh MK, Mukhopadhyay S, Roy S, Mandal C. Natural products: promising resources for cancer drug discovery. Anticancer Agents Med Chem 2012;12:49-75.
24. Zhao YG, Wang Y, Guo Z, Dan HC, Baldwin AS, Hao W, et al. Dihydroartemisinin ameliorates inflammatory disease by its reciprocal effects on Th and regulatory T cell function via modulating the mammalian target of rapamycin pathway. J Immunol 2012;189:4417-4425.
25. Wang X, Huang M, Wang Y. The effect of insulin, TNFα and DHA on the proliferation, differentiation and lipolysis of preadipocytes isolated from large yellow croaker (Pseudosciaena crocea R.). PloS One 2012;7:e48069.
26. Zhang G, Panigrahy D, Mahakian LM, Yang J, Liu J-Y, Lee KSS, et al. Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. P Natl Acad Sci 2013;110:6530-6535.
27. Aung W, Sogawa C, Furukawa T, Saga T. Anticancer effect of dihydroartemisinin (DHA) in a pancreatic tumor model evaluated by conventional methods and optical imaging. Anticancer Res 2011;31:1549-1558.
28. Efferth T, Rucker G, Falkenberg M, Manns D, Olbrich A, Fabry U, et al. Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs. Arzneimittel-Forsch 1996;46:196-200.
29. Konkimalla VB, Blunder M, Korn B, Soomro SA, Jansen H, Chang W, et al. Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells. Nitric Oxide 2008;19:184-191.
30. Reichert S, Reinboldt V, Hehlgans S, Efferth T, Rodel C, Rodel F. A radiosensitizing effect of artesunate in glioblastoma cells is associated with a diminished expression of the inhibitor of apoptosis protein survivin. Radiother Oncol 2012;103:394-401.
31. Mu D, Chen W, Yu B, Zhang C, Zhang Y, Qi H. Calcium and survivin are involved in the induction of apoptosis by dihydroartemisinin in human lung cancer SPC-A-1 cells. Method Find Exp Clin 2007;29:33-38.
32. Sankari SL, Masthan K, Babu NA, Bhattacharjee T, Elumalai M. Apoptosis in cancer - an update. Asian Pac J Cancer Prev 2012;13:4873-4878.
33. Nam W, Tak J, Ryu JK, Jung M, Yook JI, Kim HJ, et al. Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells. Head Neck 2007;29:335-340.
34. Youns M, Efferth T, Reichling J, Fellenberg K, Bauer A, Hoheisel JD. Gene expression profiling identifies novel key players involved in the cytotoxic effect of artesunate on pancreatic cancer cells. Biochem Pharmacol 2009;78:273-283.
35. Lu YY, Chen TS, Qu JL, Pan WL, Sun L, Wei XB. Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells. J Biomed Sci 2009;16:16.
36. Xu W, Lin H, Zhang Y, Chen X, Hua B, Hou W, et al. Compound Kushen injection suppresses human breast cancer stem-like cells by down-regulating the canonicalWnt/b-catenin pathway. J Exp Clin Cancer Res 2011;30:103.
37. Larriba MJ, González-Sancho JM, Barbáchano A, Niell N, Ferrer-Mayorga G, Muñoz A. Vitamin D is a multilevel repressor of Wnt/b-catenin signaling in cancer cells. Cancers 2013;5:1242-1260.
38. Juan J, Muraguchi T, Iezza G, Sears RC, McMahon M. Diminished WNT→ β-catenin →c-myc signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors. Gene Dev 2014;28:561-575.
39. Yin X, Xiang T, Li L, Su X, Shu X, Luo X, et al. DACT1, an antagonist to Wnt/b-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer. Breast Cancer 2013;4:5.
40. Li LN, Zhang HD, Yuan SJ, Yang DX, Wang L, Sun ZX. Differential sensitivity of colorectal cancer cell lines to artesunate is associated with expression of beta-catenin and E-cadherin. Eur J Pharmacol 2008;588:1-8.
41. Li LN, Zhang HD, Yuan SJ, Tian ZY, Wang L, Sun ZX. Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/beta-catenin pathway. Int J Cancer, 121:1360-1365.
42. Gong Y, Gallis BM, Goodlett DR, Yang Y, Lu H, Lacoste E, et al. Effects of transferrin conjugates of artemisinin and artemisinin dimer on breast cancer cell lines. Anticancer Res 2013;33:123-132.
43. Liu Y, Wang W, Xu J, Li L, Dong Q, Shi Q, et al. Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/betacatenin signaling. Oncol Rep 2013;30:1723-1730.